Pickering, Canada

Zoltan Bodor

USPTO Granted Patents = 9 

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 179(Granted Patents)


Company Filing History:


Years Active: 1988-2012

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Zoltan Bodor: Pioneering Spill Resistant Formulations

Introduction

Zoltan Bodor, an innovative inventor based in Pickering, Canada, has made significant contributions to the field of pharmaceutical formulations. With a remarkable portfolio of nine patents to his name, he is recognized for his research that enhances the usability and efficiency of pharmaceutical compositions.

Latest Patents

Among his notable patents are his groundbreaking work on spill resistant formulations containing clays. This invention encompasses novel formulations that include a weak base or a weak acid as the pharmaceutical ingredient, a liquid base, clay, and a water-soluble cellulose ether. The unique combination of clay and cellulose ether enables a broader pH range for the dispersion or dissolution of pharmaceutically active agents, facilitating an easier preparation and formulation process for pharmaceutical compositions.

Career Highlights

Zoltan has cultivated his expertise through his tenure at prominent companies in the pharmaceutical industry, including Warner-Lambert Company and Taro Pharmaceuticals U.S.A., Inc. His experience at these firms has solidified his role as a key player in the advancement of effective pharmaceutical solutions.

Collaborations

Throughout his career, Zoltan has had the pleasure of collaborating with talented individuals such as Zdravko Dokuzovic and Satish Asotra. These partnerships have fostered a stimulating environment for innovation and problem-solving within the pharmaceutical field.

Conclusion

Zoltan Bodor's inventive contributions, particularly in the realm of spill resistant formulations, showcase his dedication to advancing pharmaceutical technologies. With nine patents highlighting his ingenuity and collaborative spirit, he continues to influence the industry positively, paving the way for improved pharmaceutical formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…